| Literature DB >> 30322189 |
Maria Manconi1, Maria Letizia Manca2, Carla Caddeo3, Giorgia Sarais4, Alessandra Palmieri5, Guy D'Hallewin6, Anna Maria Fadda7.
Abstract
Background: The nanoincorporation of the extract of Citrus limon (L.) Osbeck var. pompia into liposomes was aimed at improving its antioxidant and antibacterial effects.Entities:
Keywords: Citrus extract; antimicrobial; antioxidant; oxidative stress; phospholipid vesicles
Year: 2018 PMID: 30322189 PMCID: PMC6313442 DOI: 10.3390/medicines5040108
Source DB: PubMed Journal: Medicines (Basel) ISSN: 2305-6320
Composition (mg/mL) of liposomes, glycerosomes and propylene glycol-penetration enhancers containing vesicles (PG-PEVs).
| Formulation | Extract (mg) | S75 (mg) | Glycerol (mL) | PG (mL) | H2O (mL) |
|---|---|---|---|---|---|
| Liposomes | 80 | 120 | 0 | 0 | 1.00 |
| 12glycerosomes | 80 | 120 | 0.25 | 0 | 1.75 |
| 25glycerosomes | 80 | 120 | 0.50 | 0 | 1.50 |
| 50glycerosomes | 80 | 120 | 1.00 | 0 | 1.00 |
| 12PG-PEVs | 80 | 120 | 0 | 0.25 | 1.75 |
| 25PG-PEVs | 80 | 120 | 0 | 0.50 | 1.50 |
| 50PG-PEVs | 80 | 120 | 0 | 1.00 | 1.00 |
S75: Lipoid S75. PG: propylene glycol.
Main components of the pompia extract.
| Analyte | µg/mg |
|---|---|
| Gallic acid | 128.3 ± 10.9 |
| Eriocitrin | 40.4 ± 2.1 |
| Neoeriocitrin | 42.5 ± 3.5 |
| Naringin | 28.0 ± 1.6 |
| Hesperidin | 16.9 ± 0.9 |
| Neohesperidin | 76.5 ± 3.8 |
| Myricetin 3-galactoside | 29.3 ± 1.4 |
Figure 1TEM images of pompia extract loaded liposomes (A), glycerosomes (B) and PG-PEVs (C).
Mean diameter (MD), polydispersity index (PI), zeta potential (ZP) and entrapment efficiency (EE) of empty and pompia extract loaded liposomes, glycerosomes and PG-PEVs. Mean values ± standard deviation (SD) were calculated from at least 3 replicates.
| Formulation | MD (nm ± SD) | PI | ZP (mV ± SD) | EE (% ± SD) |
|---|---|---|---|---|
| Empty liposomes | 64 ± 7 | 0.25 | −69 ± 4 | |
| Empty 12glycerosomes | 65 ± 6 | 0.25 | −78 ± 3 | |
| Empty 25glycerosomes | 96 ± 6 | 0.27 | −77 ± 4 | |
| Empty 50glycerosomes | 106 ± 6 | 0.316 | −70 ± 3 | |
| Empty 12PG-PEVs | 87 ± 78 | 0.26 | −76 ± 6 | |
| Empty 25PG-PEVs | 99 ± 8 | 0.29 | −76 ± 4 | |
| Empty 50PG-PEVs | 105 ± 7 | 0.27 | −76 ± 5 | |
| 137 ± 16 | 0.26 | −43 ± 4 | 59 ± 11 | |
| 139 ± 2 | 0.18 | −40 ± 3 | 68 ± 11 | |
| 157 ± 13 | 0.22 | −40 ± 9 | 65 ± 9 | |
| 181 ± 33 | 0.25 | −48 ± 6 | 66 ± 12 | |
| 133 ± 18 | 0.35 | −49 ± 4 | 63 ± 9 | |
| 152 ± 16 | 0.34 | −39 ± 6 | 61 ± 8 | |
| 218 ± 28 | 0.39 | −45 ± 5 | 64 ± 10 |
Figure 2Viability of keratinocytes stressed with hydrogen peroxide and simultaneously treated with the pompia extract in dispersion or loaded in the vesicular formulations. Mean values ± standard deviations are reported. # and * symbols indicate statistical differences between samples.
Inhibition halo (IH) for pompia extract in dispersion or loaded in the vesicular formulations against S. mutans, L. acidophilus, and S. sanguinis. Mean values ± standard deviation (SD) are reported.
| Formulation | IH (mm ± SD) | ||
|---|---|---|---|
|
|
|
| |
| 10 ± 5 | 10 ± 4 | 8 ± 4 | |
| 12 ± 5 | 10 ± 3 | 13 ± 4 | |
| 11 ± 5 | 12 ± 3 | 12 ± 4 | |
| 12 ± 5 | 12 ± 4 | 13 ± 4 | |
| 12 ± 4 | 13 ± 2 | 12 ± 3 | |
| 11 ± 3 | 12 ± 5 | 14 ± 3 | |
| 12 ± 4 | 10 ± 4 | 13 ± 5 | |
| 10 ± 5 | 11 ± 5 | 14 ± 4 | |